Limiting-dilution analysis of long-term culture-initiating cells (LTCIC) is a quantitative method of estimating hematopoietic stem cell activity in clinical samples. We compared the numbers of LTCIC in bone marrow (BM), umbilical cord blood, and blood progenitor cells (obtained from patients with solid tumors at leukapheresis after mobilization with induction chemotherapy and filgrastim administration), using a two-stage long-term culture system and a limitingdilution technique, scoring cobblestone areas of greater than 15 hematopoietic cells weekly for up to 8 weeks. Samples were obtained from 30 normal BMs, 20 human umbilical cords, and 32 leukapheresis products. Direct comparison of LTCIC in the three sources showed that the median proportions of cells generating hematopoietic foci from unfractionated mononuclear cells at 5 and 8 weeks, respectively, were 1:13,314 and 1:33,949 for BM, 1:12,506 and 1:34,546 for um-EMATOPOIETIC cells are increasingly being used for autologous and allogeneic transplantation, support of intensive multicyclic chemotherapy, and gene transfer protocols. These various applications may be best served by different blood products and mobilizing regimens. For example, a mixture of early and late progenitors might be desirable for transplantation to ensure both rapid and sustained engraftment. However, for allogeneic transplantation the need to reduce immunogenicity might favor umbilical cord blood,' whereas the maximum yield of very primitive cells might be required for gene therapy.
Bone marrow (BM), peripheral blood stem cells, and umbilical cord blood have all been used as sources of hematopoietic cells.24 Long-term culture of each of these blood products has shown the presence of cells capable of generating sustained hematopoiesis in However, such assays only estimate total numbers of colony-forming cells (CFC) generated from an inoculum and do not permit a quantitative estimate of the stem cells giving rise to the CFC.
Long-term culture-initiating cells (LTCIC) are the best available approximation of stem cells in humans. ' We have developed a quantitative method of limiting-dilution analysis using cobblestone-area-forming cells (CAFC) to estimate numbers of LTCIC. In an animal model, a good correlation was observed between the frequency of day 28 CAFC and marrow-repopulating cells.839 We have used unfractionated samples and scored at a single time point, to compare BM, umbilical cord blood, and leukapheresis product to define the minimum inoculum containing LTCIC.
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MATERIALS AND METHODS
Normal BM was obtained from allogeneic BM donors. The first aspirate was used for all experiments. Samples were collected into Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY) containing 20% fetal calf serum (FCS; Flow Laboratories, Imine, CA) and preservative-free heparin. Samples were transported at room temperature and processed within 4 hours. Umbilical cord blood was collected, with the mothers' informed consent, from the umbilical cords of normal infants? After placental delivery, the umBlood, Vol84, No 11 (December I ) , 1994: pp 3653-3659 bilical cord blood, and 1:10,302 and 1:12,891 for leukapheresis product. The estimated proportions of LTCIC from unfractionated mononuclear cells and CD34' cells were similar in experiments with leukapheresis product. Leukapheresis product was superior to umbilical cord blood and cord blood to BM at 5 and 8 weeks of culture (P = .01). In two-stage long-term cultures, more colonies per flask and CD34' cells were found in assays of leukapheresis product than in BM or umbilical cord blood cultures (P= .0005). Results obtained by this simplified limiting-dilution analysis cormlated well with standard long-term cultures and can be used as a measure of the stem cell population. These data suggest that the incidence of putative stem cells in leukapheresis product and umbilical cord blood are at least comparable with that of BM. 0 1994 by The American Society of Hematology.
bilical veins were cannulated and aspirated. Blood was collected into 20% human AB serum in WMI-1640 medium (GIBCO) containing preservative-free heparin. The samples were transported at room temperature and processed within 18 to 24 hours of collection. Leukapheresis samples were obtained from patients with high-grade lymphoma or solid tumors proceeding to high-dose therapy and blood cell transplantation. They had no more than one previous chemotherapy regimen and no prior radiotherapy. The cells were mobilized with chemotherapy followed by administration of filgrastim 300 pg subcutaneously for 7 to 9 days6 Leukapheresis samples were collected in autologous plasma with citrate anticoagulation. They were transported at room temperature and processed within 4 hours. Patients had no BM metastases and no primary hematologic disease. All Long-term cultures. The capacity of the mononuclear cells to repopulate BM stroma was tested in two-stage long-term cultures."' BM stromal cells for these cultures were obtained from normal allogeneic transplant donors. Stromal layers from the same donor were used to test all samples from each patient. After 4 to 8 weeks of culture, these stromal cultures were exposed to 16 Gy y irradiation from a '37Cesium source at a rate of 6.28 cGy/s to ablate endogenous hematopoiesis. The growth medium was removed, leaving irradiated stromal layers ready for inoculation of the test hemopoietic cells.
Ficoll-separated and adherent-cell-depleted BM and peripheral blood mononuclear cells were inoculated on preformed irradiated stromal layers. Adherent cells were removed by overnight incubation in plastic flasks containing 2 X lo6 cells/mL IMDM supplemented with 15% FCS and incubated at 37°C in 5% CO, in air. Nonadherent cells, IO6, were seeded onto stroma in a total volume of 10 mL.
Culture supernatants were monitored by determining the total number of nucleated cells and the number of GM-CFC in the supernatant at the time of the weekly feeding. The nonadherent cells were washed once in IMDM containing 2% FCS, counted, and plated in a CFC assay as described above. Cells, 5 X IO4, were inoculated in triplicate wells and the cultures were read on day 14.
LTCIC assays. Normal BM stroma were established in the inner wells of 96-well tissue culture plates (Falcon). The outer wells were filled with distilled water. Mononuclear cells separated in 1% methylcellulose were diluted to a final concentration of 2 X 106/mL in long-term culture medium and 120 pL placed in the remaining 60 wells. The plates were incubated at 37°C in 5% CO2 in air. Plates were fed by semidepletion weekly.
Stromal layers were irradiated when confluent (at 3 to 4 weeks) using a linear-accelerator (10 million electron volts) to a dose of 16 Gy to ablate endogenous hematopoiesis. Mononuclear cells were separated using Ficoll and depleted of adherent cells before inoculation onto the preirradiated stromal layers. Four dilutions were used, with 30 replicate wells for each. A minimum of 3 X lo' and a maximum of 3.5 X lo4 mononuclear cells/mL (or 30 to 600 CD34+ cells mL) were plated. The dilutions were chosen to be maximally informative at weeks 5 to 6 of the assay, yielding 10% to 37% negative wells for cobblestone areas. These were defined as clusters of small, tightly packed cells that were nonrefractory when viewed under a phase contrast microscope and originated from a CAFC" (Fig 1) . Wells with cobblestone areas of greater than 15 cells or three separate foci of more than five cells were scored as positive using an inverted phase contrast microscope, weekly for 8 weeks.
Twenty to 30 replicates in the informative range were required to give a reliable estimate for dilutions using a binomial model." Some experiments were terminated at week 5 and clonogenic CFC assays performed on each replicate well. The adherent layer was washed and treated with .25% trypsin at 37°C. After 10 minutes, trypsinisation was stopped by adding fetal calf serum. After centrifugation for 10 minutes at 400g, the adherent cells were resuspended in their corresponding supernatant and a standard GM-CFC assay in agar performed."
Statistical methods. Comparisons were made using standard statistical tests. Results are expressed as median -C range except where otherwise stated. Baseline comparisons used Kruskal-Wallis tests. Long-term culture profiles were compared using repeated measures analyses of variance, assuming missing data to be missing at random. An unstructured covariance matrix was assumed and reported tests on differences between means are likelihood ratio tests. Estimates of LTCIC proportions were analyzed by standard limiting-dilution assay techniques.'* The assumptions of this model are: (1) Homogeneous suspension of LTCIC in each dilution. (2) A single LTCIC in a well will result in a positive cobblestone area, ie, a single-hit model.
RESULTS
Samples were obtained from 30 normal BM donors, 20 umbilical cords, and 32 leukapheresis procedures. The number of CFCs and the proportion of CD34' cells in samples containing lo6 mononuclear cells from the freshly collected normal BM, cord blood, and leukapheresis product were compared. GM-CFC numbers were significantly higher in the leukapheresis harvest (median, 4,255, range, 834 to 9,200) than in normal BM (median, 1,170, range, 300 to 3,740) or umbilical cord blood (median, 1,825, range, 520 to 3,400; P = .0005, Kruskal-Wallis). In addition, the proportion of CD34' cells was significantly higher in the ieukapheresis product (median, 3.7%. range, 0.5 to 18) than in normal BM (median, 1.48%, range, 0.4 to 8.3) or umbilical cord blood (median, 1.13%, range, 0.56 to 3.9; P = .002, Kruskal-Wallis).
Standard long-term cultures. The behavior of hematopoietic cells from BM, umbilical cord blood, and leukapheresis product in standard long-term cultures are compared in Fig 2. Although in some cultures the numbers of supernatant CFCs increased between weeks 0 and 5, by week 8 there were fewer than week 0 in every case. The slope (rate of decline) in mean numbers of supernatant CFC did not differ significantly between the three groups ( P = .11). However, colony numbers differed between them throughout ( P .0001). The leukapheresis product gave rise to significantly more supernatant CFC than umbilical cord blood ( P = .001) and umbilical cord blood CFC counts were higher than that of BM ( P = .08). These data show a higher capacity to generate CFC in the leukapheresis products than in normal BM or umbilical cord blood but give no indication of the number of stem cells.
Estimation of LTCIC in leukapheresis product by limitingdilution analysis. Data from two representative assays are shown in Fig 3 on a complementary log-log plot. Assuming that rj follows a binomial distribution, and that the number of LTCIC in any inoculum follows a Poisson distribution, the following linear relationship holds:
For in the inoculum; and 4 is the proportion of LTCIC in the inoculum to be estimated.
This equation describes a straight line with slope 1.0 and intercept In4 that was fitted using a maximum likelihood estimate with the statistical modeling package generalized linear interactive modeling (GLIM)." The variability of the plotted points was not assumed to be constant. A Pearson goodness-of-fit test was performed for each individual data set. In the experiments shown below, significant lack of fit at the 5% level was found in 14 of 105 (13%) of data sets shown in Fig 4, and in 6% of those in later experiments. Those with significant lack of fit were not used for comparative purposes. Direct comparison by limiting-dilution analysis of BM, umbilical cord blood, and leukapheresis product over 8 weeks in culture. The proportion of CAFC with time was compared directly in cultures of BM, umbilical cord blood, and leukapheresis product inoculated onto stromal layers derived from the same donor sample in six experiments from each group (n = 18, Fig 4) . After an initial increase, the proportion of CAFC plateaued at 1:103 to ]:IO4 at weeks 3 to 6. The numbers of cobblestone areas then gradually decreased during weeks 6 to 8, especially in BM and umbilical cord blood. The proportion of CAFC per mononuclear cell at week 5 was 1:9,291 (1:3,296 to 17,602) in BM samples, 1:4,343 (1:3,857 to 15,209) in umbilical cord blood, and " " " " " _ " " " " " " " " " " "
"""""". Comparison of BM, umbilical cord blood, and leukapheresis product using a single estimate of LTCIC derived by limiting-dilution analysis. Because committed progenitors in the inoculum contribute to hematopoietic activity in the first 4 weeks of long-term cultures, and because estimated CAFC numbers plateau between weeks 3 and 6 of culture, in subsequent experiments CAFC were scored at week 5 or 6 of culture only. For these experiments, five dilution steps were used (each with 30 replicates) in the informative range. Using this extended data set (n = 41), the median calculated proportion of CAFC in unfractionated cells at week 5 of culture for 12 BMs was 1:13,314 mononuclear cells (range, 4,024 to 22,657), for 9 umbilical cord bloods 1: 12,506 mononuclear cells (range, 3,857 to 21,2441, and for 1 1 leukapheresis products 1:10,302 mononuclear cells (range 2,252 to 52,060).
To determine whether similar estimates of LTCIC were obtained from total mononuclear cell and CD34+ cell frac- Incidence of LTCIC estimated by clonogenic cells and CAFC. The production of GM-CFC in the supernatant and adherent layers of each individual well were measured in 5 BM, 4 umbilical cord bloods, and 5 leukapheresis product cultures at week 5. GM-CFC numbers correlated with the presence of CAFC (Fig 5; r = . 73,95% confidence interval [CI] 0.32,0.91). Trypsinization and manipulation of the cultures resulted in lower estimates of LTCIC obtained from GM-CFC than CAFC, with a mean difference of -0.1, but this was not statistically significant ( P = .11, two-tailed ttest). False negatives, ie, wells negative for cobblestone areas For personal use only. on August 30, 2017. by guest www.bloodjournal.org From but positive for GM-CFC or vice versa, were rarely detected (total 6%, Table 1 ).
In a single experiment of CD34' selected cells (58 wells) assayed at 8 weeks of culture the proliferative potential of individual LTCIC was determined from the number of GM-CFC per well, as per Sutherland et al. ' LTCIC estimated by CAFC was 1:157 and by GM-CFC 1: 147. The number of colonies in positive wells ranged from 1 to 49 GM-CFC per well. The number of clonogenic progenitors per LTCIC was calculated to be 6: 1.
DISCUSSION
This study describes the use of a simplified limiting-dilution assay in vitro to estimate the frequency of LTCIC as a measure of the putative stem cell in hematopoietic cells from different sources. We have confirmed in this system that the number of CAFC and GM-CFC are related to the number of cells inoculated so that both CAFC and GM-CFC can be used as endpoint measures in the three hematopoietic substrates (Fig 5) . This does not necessarily imply that they are measuring the same stem cell population. Previous investigators have undertaken detailed studies using samples enriched by T-cell depletion and soya bean aggl~tinin'~ or FACS subset a n a l y s i~~. '~ to characterize the stem cell subpopulations throughout the assay period. They have validated the assay of LTCIC as a measure of hematopoietic stem cells in mice, but definitive evidence is not available in humans. We have used CD34+ and unfractionated mononuclear cells to assess the proportion of LTCIC at weeks 5 through 6 of culture and have obtained similar estimates. These data also suggest that any accessory cells in unfractionated samples do not influence the progenitor cell population measured using this experimental design. Because these assays are very labor intensive, our observation that the assay can be simplified by inoculating unfractionated mononuclear cells and by scoring CAFC or GM-CFC at a single time point is of practical value.
Estimates of the proportion of LTCIC derived by limitingdilution analysis are consistent with the description of hematopoietic activity obtained by measuring CFC production in standard long-term cultures. In the LTCIC assays, different progenitor cell populations contribute to hematopoiesis over the observation period."" The dynamic nature of cobblestone areas in culture enables the contributions of the different progenitor populations responsible for short-term and longer-term engraftment to be assessed (Fig 4) . This is consistent with previous studies of mice in which unfractionated and fractionated BM cells were simultaneously assayed in vivo and long-term culture initiating cell assay^.^." The inoculated committed progenitors mature by week 4 and hematopoietic activity observed after this time is generated within the cultures by more primitive cells.
Our data confirm the observations of Sutherland et a l ' that at week 5 and week 8 different progenitor cell subpopulations are contributing to hematopoietic activity. Enrichment
For personal use only. on August 30, 2017. by guest www.bloodjournal.org From of early progenitors by selection of CD34+ cell subsets, CD33-15 HLA-DR10w,'4.'6 rhodamine-l23 dull," and 4-hydroperoxycyclophosphamide re~istant'~.'~.'~.'~ are necessary to determine the contributions of the various cell populations to hematopoiesis at different time points and determine whether assessment at week 8 better represents the more primitive stem cell population than assessment at week 5. Even so, this methodology could still be usefully applied.
A variety of cytokines, alone and in combination, have been shown to mobilize hematopoietic progenitors into the circulation. The mix of different progenitors released may vary with the mobilizing regimen used. Numbers of GM-CFC and CD34' cells are routinely used to assess the engraftment potential of BM and leukapheresis harvests.*' These parameters predominantly reflect clonogenic cell activity which might only be relevant to short-term hematopoietic reconstitution" and not necessarily reflect the presence of a more primitive population capable of sustained engraftment."
The proportion of LTCIC in unstimulated peripheral blood and normal BM has been rep~rted.~.'~ Here we have shown that hematopoietic progenitors from BM, umbilical cord blood, and leukapheresis product behave similarly in culture. Increased hematopoiesis is caused by an increased proportion of primitive progenitors in the umbilical cord blood and leukapheresis products compared with BM. This is consistent with data showing that hematopoietic progenitors from mobilized peripheral blood and umbilical cord blood persist longer in long-term culture than BM cell^.^,^ It is important to note that the leukapheresis products studied were obtained from patients undergoing induction chemotherapy, who had not been subjected to extensive pretreatment. Chemotherapy and G-CSF were used to mobilize progenitor cells into the peripheral blood. It would be unwise to extrapolate from these data to leukapheresis products obtained with different mobilizing regimens or from a heavily pretreated group of patients. At week 5 of culture, the proportion of LTCIC was about l: lo4 for all three hematopoietic sources. At week 8 this proportion was maintained in the leukapheresis product, however it fell in umbilical cord blood to 1:2 X lo4 and in BM to 1:3 X lo4. Sutherland et ai7 have reported the proportion of LTCIC in BM at week 5 to be approximately 1:2 X lo4. We have shown that plating efficiency is reduced by about 10% between CAFC and colonies (Fig S) , which is the endpoint for the Canadian assay. Taking into account sample variability and differences in experimental design, these results are comparable.
At present, hematopoietic cells are mainly used for autologous and allogeneic transplantation. BM cells have long been used for both. In addition, hematopoietic stem cells are attracting interest as a source of cells for gene transfer and gene therapy. We have shown that umbilical cord blood and leukapheresis product are at least as good a source of LTCIC as BM for transplantation. The limiting-dilution analysis technique allows characterization of the diverse hematopoietic cell products and will assist in designing optimal mobilizing regimens.
In summary, the results of limiting-dilution analysis correlate well with hematopoietic activity in standard long-term culture and may be useful in characterizing the stem cell population. In both standard long-term culture and limitingdilution analysis, the proportion of LTCIC in peripheral blood stem cells primed with chemotherapy and filgrastim is similar to or higher than that of BM and umbilical cord blood. The transplantation potential of primed peripheral blood stem cells and umbilical cord blood is at least as good as that of BM.
